Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK221149A in healthy pregnant women with uncomplicated preterm labor
2006-005807-32Phase 2Terminated
- Sponsor
- GSK
- Start
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Preterm labor (PTL) comparing GSK221149A with Placebo (2 arms). Primary endpoints: Safety and tolerability of intravenous GSK221149A, Pharmacokinetics of intravenous GSK221149A and 2 more. Started May 2007; status: terminated.
02
Drugs
retosiban
03
Conditions
Preterm labor (PTL)
Beyond the preview
Go deeper on 2006-005807-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005807-32.